Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Carcinoma, Renal Cell
×
palbociclib
×
Clear all
Filters
3
NCT07405164
2026-02-12
MK-6482-043
Merck Sharp & Dohme LLC
Phase 3
Not yet recruiting
450 enrolled
NCT05468697
2026-01-23
MK-6482-024
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
60 enrolled